A Phase II Study of Cisplatin, Ifosfamide and Epirubicin Combination Chemotherapy in Adults with Nonmetastatic and Extremity Osteosarcomas

Publisher： Karger

E-ISSN： 1423-0232|72|3-4|255-260

ISSN： 0030-2414

Source： Oncology, Vol.72, Iss.3-4, 2008-01, pp. : 255-260

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase II Study of Epirubicin, Cisplatin and Capecitabine Combination Chemotherapy in Patients with Metastatic or Advanced Gastric Cancer

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 333-340

Karger

Access to resources Recommend Favorite

Multicenter Phase I/II Study of Docetaxel, Cisplatin and Fluorouracil Combination Chemotherapy in Patients with Advanced or Recurrent Squamous Cell Carcinoma of the Esophagus

By  

Oncology, Vol. 80, Iss. 5-6, 2011-07 ,pp. : 307-313

Karger

Access to resources Recommend Favorite

Phase II Study of Cisplatin, Epirubicin, and Continuous-Infusion 5-Fluorouracil for Advanced Biliary Tract Cancer

By  

Oncology, Vol. 64, Iss. 4, 2003-05 ,pp. : 475-476

Karger

Access to resources Recommend Favorite

A Phase I/II Study of Dose-Escalated Ifosfamide plus Carboplatin Combination for Advanced Ovarian Carcinoma

By  

Oncology Research and Treatment, Vol. 22, Iss. 3, 1999-07 ,pp. : 212-215

Karger

Access to resources Recommend Favorite

A Phase II Study of the Docetaxel- Ifosfamide-Carboplatin Combination in Advanced Non-Small-Cell Lung Cancer

By  

Oncology, Vol. 69, Iss. 4, 2005-12 ,pp. : 333-341

Karger

Access to resources Recommend Favorite